286 related articles for article (PubMed ID: 22173586)
1. Era of personalized medicine may herald end of soaring cancer costs.
Keogh B
J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
[No Abstract] [Full Text] [Related]
2. Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs.
Amir E; Seruga B; Martinez-Lopez J; Kwong R; Pandiella A; Tannock IF; Ocaña A
J Clin Oncol; 2011 Jun; 29(18):2543-9. PubMed ID: 21606435
[TBL] [Abstract][Full Text] [Related]
3. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
Parkinson DR; Johnson BE; Sledge GW
Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
[TBL] [Abstract][Full Text] [Related]
4. Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis.
Tirelli U; Berretta M; Bearz A; Carbone A
Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1355-6. PubMed ID: 22195374
[No Abstract] [Full Text] [Related]
5. The era of cancer discovery.
Cantley LC; Baselga J
Cancer Discov; 2011 Jun; 1(1):1. PubMed ID: 22586302
[No Abstract] [Full Text] [Related]
6. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
Scolyer RA; Thompson JF
J Surg Oncol; 2013 Jun; 107(7):681-2. PubMed ID: 23280671
[No Abstract] [Full Text] [Related]
7. Early phase clinical trials in pediatric hematology and oncology.
Corbacioglu S
Klin Padiatr; 2012 Apr; 224(3):197-200. PubMed ID: 22511313
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies in oncology--a challenge for clinical and academic pathology].
Röcken C
Dtsch Med Wochenschr; 2013 May; 138(20):1073-6. PubMed ID: 23670265
[No Abstract] [Full Text] [Related]
9. Targeted immunotherapies overtaking emerging oncology market value based growth.
Jakovljevic MB
J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
[No Abstract] [Full Text] [Related]
10. Economic burden of dermatologic adverse events induced by molecularly targeted cancer agents.
Borovicka JH; Calahan C; Gandhi M; Abraham TS; Kwasny MJ; Haley AC; West DP; Lacouture ME
Arch Dermatol; 2011 Dec; 147(12):1403-9. PubMed ID: 22184762
[TBL] [Abstract][Full Text] [Related]
11. Placing bets on biotech.
Weintraub K
Cancer Discov; 2011 Nov; 1(6):462. PubMed ID: 22586641
[No Abstract] [Full Text] [Related]
12. [Economic effects of "molecular" medicine].
Riemann JF
Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1740. PubMed ID: 17713881
[No Abstract] [Full Text] [Related]
13. Can treatment costs be tamed?
Malakoff D
Science; 2011 Mar; 331(6024):1545-7. PubMed ID: 21436438
[No Abstract] [Full Text] [Related]
14. [Health care expenditures linked to the use of targeted therapies and diagnostic tests for cancer patients].
Marino P; Bertucci F; Gonçalves A; Seror V
Med Sci (Paris); 2012 Mar; 28 Spec No 1():19-23. PubMed ID: 22494652
[TBL] [Abstract][Full Text] [Related]
15. Getting personal.
Nature; 2011 May; 473(7347):253-4. PubMed ID: 21593815
[No Abstract] [Full Text] [Related]
16. The economics of improved cancer survival rates: better outcomes, higher costs.
Uyl-de Groot CA; de Groot S; Steenhoek A
Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):283-92. PubMed ID: 20545593
[TBL] [Abstract][Full Text] [Related]
17. Outpatient cancer drug costs: changes, drivers, and the future.
Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
19. Just caring: assessing the ethical and economic costs of personalized medicine.
Fleck LM
Urol Oncol; 2014 Feb; 32(2):202-6. PubMed ID: 24445288
[TBL] [Abstract][Full Text] [Related]
20. Toward molecular imaging-driven drug development in oncology.
de Vries EG; Oude Munnink TH; van Vugt MA; Nagengast WB
Cancer Discov; 2011 Jun; 1(1):25-8. PubMed ID: 22586317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
